Pieter B. M. W. M. Timmermans
Directeur Technique/Scientifique/R&D chez Kosan Biosciences, Inc.
Profil
Pieter B.
M.
W.
M.
Timmermans is a professional with a background in drug discovery and preclinical research.
He is currently employed as the SVP-Drug Discovery & Preclinical Research at Kosan Biosciences, Inc. Prior to this, he held the position of VP-Pharmacology & Preclinical Development at Amgen, Inc. and Tularik, Inc. respectively.
He also worked as an Associate Professor at the University of Amsterdam.
Timmermans received his undergraduate and doctorate degrees from the University of Leiden.
Postes actifs de Pieter B. M. W. M. Timmermans
| Sociétés | Poste | Début |
|---|---|---|
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Directeur Technique/Scientifique/R&D | 01/01/2005 |
Anciens postes connus de Pieter B. M. W. M. Timmermans
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/01/2005 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2004 |
| University of Amsterdam | Corporate Officer/Principal | - |
Formation de Pieter B. M. W. M. Timmermans
| University of Leiden | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |